Publikationen, an denen er mitarbeitet LUIS MIGUEL ORTEGA MORA (22)

2024

  1. An Early Treatment With BKI-1748 Exhibits Full Protection Against Abortion and Congenital Infection in Sheep Experimentally Infected With Toxoplasma gondii

    Journal of Infectious Diseases, Vol. 229, Núm. 2, pp. 558-566

  2. Evaluating the suitability of placental bovine explants for ex vivo modelling of host-pathogen interactions in Neospora caninum infections

    Theriogenology, Vol. 230, pp. 305-313

2023

  1. A comparative study of serological tests used in the diagnosis of Toxoplasma gondii infection in small ruminants evidenced the importance of cross-reactions for harmonizing diagnostic performance

    Research in Veterinary Science, Vol. 165

  2. A questionnaire-based survey in Spain provides relevant information to improve the control of ovine coccidiosis

    Frontiers in Veterinary Science, Vol. 10

  3. Experimental infection of sheep at mid-pregnancy with archetypal type II and type III Toxoplasma gondii isolates exhibited different phenotypic traits

    Veterinary Parasitology, Vol. 315

  4. Ovine placental explants: A new ex vivo model to study host‒pathogen interactions in reproductive pathogens

    Theriogenology, Vol. 212, pp. 157-171

2022

  1. A new inactivated Tritrichomonas foetus vaccine that improves genital clearance of the infection and calving intervals in cattle

    Frontiers in Veterinary Science, Vol. 9

  2. Archetypal type II and III Toxoplasma gondii oocysts induce different immune responses and clinical outcomes in experimentally infected piglets

    Frontiers in Immunology, Vol. 13

2021

  1. A short-term treatment with BKI-1294 does not protect foetuses from sheep experimentally infected with Neospora caninum tachyzoites during pregnancy

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 17, pp. 176-185

  2. Assessment of the activity of decoquinate and its quinoline‐ o‐carbamate derivatives against toxoplasma gondii in vitro and in pregnant mice infected with t. Gondii oocysts

    Molecules, Vol. 26, Núm. 21

  3. Dynamics of neospora caninum-associated abortions in a dairy sheep flock and results of a test-and-cull control programme

    Pathogens, Vol. 10, Núm. 11

  4. One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseases

    Veterinary Parasitology, Vol. 289

2020

  1. Characterization of Fetal Brain Damage in Early Abortions of Ovine Toxoplasmosis

    Veterinary Pathology, Vol. 57, Núm. 4, pp. 535-544

2019

  1. La neosporosis como causa de aborto en el ganado ovino y caprino

    Ganadería, Núm. 120, pp. 46-48

  2. Prevalence of bovine trichomonosis and associated risk factors in bulls from Spanish beef herds

    Theriogenology, Vol. 128, pp. 116-121

  3. Treatment with Bumped Kinase Inhibitor 1294 Is Safe and Leads to Significant Protection against Abortion and Vertical Transmission in Sheep Experimentally Infected with Toxoplasma gondii during Pregnancy

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 7

  4. Virulence in Mice of a Toxoplasma gondii Type II Isolate Does Not Correlate With the Outcome of Experimental Infection in Pregnant Sheep

    Frontiers in Cellular and Infection Microbiology, Vol. 9, Núm. JAN

2018

  1. Influence of dose and route of administration on the outcome of infection with the virulent Neospora caninum isolate Nc-Spain7 in pregnant sheep at mid-gestation

    Veterinary Research, Vol. 49, Núm. 1

  2. Safety and efficacy of the bumped kinase inhibitor BKI-1553 in pregnant sheep experimentally infected with Neospora caninum tachyzoites

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 8, Núm. 1, pp. 112-124

  3. Treatment of toxoplasmosis and neosporosis in farm ruminants: State of knowledge and future trends

    Current Topics in Medicinal Chemistry, Vol. 18, Núm. 15, pp. 1304-1323